198 related articles for article (PubMed ID: 7527180)
1. Peptide epitopes in breast cancer mucins.
Xing PX; Apostolopoulos V; Trapani J; Prenzoska J; McKenzie IF
Adv Exp Med Biol; 1994; 353():9-16. PubMed ID: 7527180
[No Abstract] [Full Text] [Related]
2. Induction of antibody responses to breast carcinoma associated mucins using synthetic peptide constructs as immunogens.
Denton G; Sekowski M; Price MR
Cancer Lett; 1993 Jul; 70(3):143-50. PubMed ID: 7689035
[TBL] [Abstract][Full Text] [Related]
3. Engineering of antibodies for breast cancer therapy: construction of chimeric and humanized versions of the murine monoclonal antibody BrE-3.
Couto JR; Blank EW; Peterson JA; Kiwan R; Padlan EA; Ceriani RL
Adv Exp Med Biol; 1994; 353():55-9. PubMed ID: 7985542
[No Abstract] [Full Text] [Related]
4. Humanization of an anti-mucin antibody for breast and ovarian cancer therapy.
Baker TS; Bose CC; Caskey-Finney HM; King DJ; Lawson AD; Lyons A; Mountain A; Owens RJ; Rolfe MR; Sehdev M
Adv Exp Med Biol; 1994; 353():61-82. PubMed ID: 7985543
[TBL] [Abstract][Full Text] [Related]
5. Characterization of monoclonal antibody 436 recognizing the Arg-Pro-Ala-Pro sequence of the polymorphic epithelial mucin (PEM) protein core in breast carcinoma cells.
Nuti M; Turchi V; Rughetti A; Viacava P; Masci AM; Castagna M; Frati L
Int J Biol Markers; 1992; 7(2):71-9. PubMed ID: 1378874
[TBL] [Abstract][Full Text] [Related]
6. Humoral immunity against a tandem repeat epitope of human mucin MUC-1 in sera from breast, pancreatic, and colon cancer patients.
Kotera Y; Fontenot JD; Pecher G; Metzgar RS; Finn OJ
Cancer Res; 1994 Jun; 54(11):2856-60. PubMed ID: 7514493
[TBL] [Abstract][Full Text] [Related]
7. Development of an anti-idiotypic antibody reactive with an antibody defining the epitope RPAP in the MUC-1 epithelial mucin core.
Bashford JL; Robins RA; Price MR
Int J Cancer; 1993 Jul; 54(5):778-83. PubMed ID: 7686886
[TBL] [Abstract][Full Text] [Related]
8. Production of anti-breast cancer monoclonal antibodies using a glutathione-S-transferase-MUC1 bacterial fusion protein.
Apostolopoulos V; Xing PX; Trapani JA; McKenzie IF
Br J Cancer; 1993 Apr; 67(4):713-20. PubMed ID: 7682431
[TBL] [Abstract][Full Text] [Related]
9. Murine immune response to cells transfected with human MUC1: immunization with cellular and synthetic antigens.
Apostolopoulos V; Xing PX; McKenzie IF
Cancer Res; 1994 Oct; 54(19):5186-93. PubMed ID: 7923138
[TBL] [Abstract][Full Text] [Related]
10. Breast mucin and associated antigens in diagnosis and therapy.
Peterson JA; Ceriani RL
Adv Exp Med Biol; 1994; 353():1-8. PubMed ID: 7527177
[No Abstract] [Full Text] [Related]
11. Recognition of peptidyl epitopes by polymorphic epithelial mucin (PEM)-specific monoclonal antibodies.
Dion AS; Smorodinsky NI; Williams CJ; Wreschner DH; Major PP; Keydar I
Hybridoma; 1991 Oct; 10(5):595-610. PubMed ID: 1804772
[TBL] [Abstract][Full Text] [Related]
12. Analysis of a heterogeneous group of human breast carcinoma associated glycoproteins bearing the Tn determinant.
Osinaga E; Pancino G; Porchet N; Berois N; De Cremoux P; Mistro D; Aubert JP; Calvo F; Roseto A
Breast Cancer Res Treat; 1994; 32(2):139-52. PubMed ID: 7532464
[TBL] [Abstract][Full Text] [Related]
13. The immunogenicity of MUC1 peptides and fusion protein.
Apostolopoulos V; Pietersz GA; Xing PX; Lees CJ; Michael M; Bishop J; McKenzie IF
Cancer Lett; 1995 Mar; 90(1):21-6. PubMed ID: 7720038
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies to detect breast cancer cells in bone marrow.
Diel IJ; Kaufmann M; Costa SD; Bastert G
Important Adv Oncol; 1994; ():143-64. PubMed ID: 8206487
[No Abstract] [Full Text] [Related]
15. The role of tumor-associated antigens in the biology and immunotherapy of breast cancer.
Taylor-Papadimitriou J; D'Souza B; Burchell J; Kyprianou N; Berdichevsky F
Ann N Y Acad Sci; 1993 Nov; 698():31-47. PubMed ID: 8279769
[No Abstract] [Full Text] [Related]
16. Recombinant breast carcinoma-associated mucins expressed in a baculovirus system contain a tumor specific epitope.
Hu P; Wright SE
Immunotechnology; 1998 Oct; 4(2):97-105. PubMed ID: 9853951
[TBL] [Abstract][Full Text] [Related]
17. Monoclonal antibodies reactive with the breast carcinoma-associated mucin core protein repeat sequence peptide also recognise the ovarian carcinoma-associated sebaceous gland antigen.
Layton GT; Devine PL; Warren JA; Birrell G; Xing PX; Ward BG; McKenzie IF
Tumour Biol; 1990; 11(5):274-86. PubMed ID: 1697426
[TBL] [Abstract][Full Text] [Related]
18. Antitumor monoclonal antibodies generated by immunization with mucins.
Gillette RW; Singleton J; Guillen D; Gilman SC
Hybridoma; 1991 Oct; 10(5):583-94. PubMed ID: 1725169
[TBL] [Abstract][Full Text] [Related]
19. Anti-peptide monoclonal antibodies to intestinal mucin 3.
Apostolopoulos V; Xing PX; McKenzie IF
J Gastroenterol Hepatol; 1995; 10(5):555-61. PubMed ID: 8963031
[TBL] [Abstract][Full Text] [Related]
20. Effect of modification of carbohydrate side chains on the reactivity of antibodies with core-protein epitopes of the MUC1 gene product.
Burchell J; Taylor-Papadimitriou J
Epithelial Cell Biol; 1993 Oct; 2(4):155-62. PubMed ID: 7505698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
